Clinical Trial Update: Evaluation of Efficacy of Dellegra in Exposure Unit [Phase 4]

View source ↗

Summary

The Phase 4 study evaluating Dellegra for allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Dellegra

Snippet

Sponsor: Sanofi | Conditions: Rhinitis Allergic | Phase 4 | Status: COMPLETED